Aerosolized surfactant in lung-lavaged adult rats: Factors influencing the therapeutic response

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 5, 2000, Pages 612-622

  Bahlmann, H ^a   Sun, B ^a   Nilsson, G ^b   Curstedt, T ^b   Robertson, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aerosols; Albumins; Bronchoalveolar lavage fluid; Capillary permeability; Pulmonary surfactants; Rats; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; CAPILLARY PERMEABILITY; LUNG FUNCTION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE;

AEROSOLS; ANIMALS; BIOLOGICAL PRODUCTS; BRONCHOALVEOLAR LAVAGE; CAPILLARY PERMEABILITY; LUNG; LUNG COMPLIANCE; OXYGEN; PHOSPHOLIPIDS; PULMONARY CIRCULATION; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0034063833     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.00521.x     Document Type: Article

References (41)

1. 1. Halliday HL, Speer CP. Strategies for surfactant therapy in established neonatal respiratory distress syndrome. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York: Marcel Dekker, 1995: 443-459.
2. 2. Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D. Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 1993: 74: 1256-1264.
3. 3. Walmrath D, Gunther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F et al. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996: 154: 57-62.
4. 4. Li W-Z, Chen W-M, Kobayashi T. Aerosolized surfactant reverses respiratory failure in lung-lavaged rats. Acta Anaesthesiol Scand 1994: 38: 82-88.
5. 5. Jorch G, Hartl H, Roth B, Kribs A, Gortner L, Schaible T et al. To the Editor: Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol 1997: 24: 222-224.
6. 6. Ellyett KM, Broadbent RS, Fawcett ER, Campbell AJ. Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit. Pediatr Res 1996: 39: 953-957.
7. 7. Henry MD, Rebello CM, Ikegami M, Jobe AH, Langenback EG, Davis JM. Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs. Am J Respir Crit Care Med 1996: 154: 366-375.
8. 8. Lewis JF, Ikegami M, Jobe AH, Tabor B. Aerosolized surfactant treatment of preterm lambs. J Appl Physiol 1991: 70: 869-876.
9. 9. Fok TF, Mazen A-E, Dolovich M, Rasid F, Kirpalani H. Nebulisation of surfactants in an animal model of neonatal respiratory distress. Arch Dis Child Fetal Neonatal Ed 1998: 78: F3-F9.
10. 10. Lewis JF, McCaig L. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993: 148: 1187-1193.
11. 11. Lewis JF, Ikegami M, Jobe AH, Absolom D. Physiologic responses and distribution of aerosolized surfactant (Survanta®) in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993: 147: 1364-1370.
12. 12. Lewis JF, Goffin J, Yue P, McCaig LA, Bjarneson D, Veldhuizen RAW. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 1996: 80: 1156-1164.
13. 13. Tashiro K, Yamada K, Li W-Z, Matsumoto Y, Kobayashi T. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats. Crit Care Med 1996: 24: 488-494.
14. 14. Lewis J, Ikegami M, Higuchi R, Jobe A, Absolom D. Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J Appl Physiol 1991: 71: 1270-1276.
15. 15. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996: 334: 1417-1421.
16. 16. Schollin J, Liljedahl M, Berggren E, Winbladh B, Robertson B, Curstedt T. Nebulized surfactant for treatment of respiratory distress syndrome: A pilot study in preterm babies. Biol Neonate 1998: 74 (Suppl 1): 51 (Abstract).
17. 17. Sun B, Curstedt T, Robertson B. Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am J Respir Crit Care Med 1996: 154: 764-770.
18. 18. Badellino MM, Morganroth ML, Cyril MG, Lynch MJ, Bolling SF, Deeb M. Hypothermia or continuous ventilation decreases ischemia-reperfusion injury in an ex vivo rat lung model. Surgery 1989: 105: 752-760.
19. 19. Anceschi MM, Robertson B, Broccucci L, Barbati A, Grossmann G, Hedenborg L et al. Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits. Exp Lung Res 1990: 16: 593-605.
20. 20. Wiseman LR, Bryson HM. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf®) in neonatal respiratory distress syndrome. Drugs 1994: 48: 386-403.
21. 21. Lachmann B, Grossmann G, Nilsson R, Robertson B. Lung mechanics during spontaneous ventilation in premature and fullterm rabbit neonates. Respir Physiol 1979: 38: 283-302.
22. 22. Cotton RB, Olsson T. Lung mechanics in respiratory distress syndrome. In: Robertson B, Taeusch W, eds. Surfactant Therapy for Lung Disease. New York: Marcel Dekker, 1995: 120-149.
23. 23. Nunn JF. Principles of measurement of compliance. In: Nunn, JF, ed. Nunn's Applied Respiratory Physiology. Oxford: Butterworth-Heinemann, 1995: 55-59.
24. 24. Taskar V, John J, Evander E, Robertson B, Jonson B. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 1997: 155: 313-320.
25. 25. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959: 234: 466-468.
26. 26. Berggren P, Eklind J, Linderholm B, Robertson B. Bubbles and computer-aided image analysis for evaluation of surfactant inhibition. Biol Neonate 1992: 61 (Suppl 1): 15-20.
27. 27. O'Doherty MJ, Thomas SHL, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulized aerosol during mechanical ventilation. Am Rev Respir Dis 1992: 146: 383-388.
28. 28. Fujiwara T, Robertson B. Pharmacology of exogenous surfactant. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant. From Molecular Biology to Clinical Practice. Amsterdam: Elsevier, 1992: 561-592.
29. 29. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 1986: 30: 321-328.
30. 30. Sood SL, Balaraman V, Finn KC, Britton B, Uyehara CFT, Easa D. Exogenous surfactants in a piglet model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1996: 153: 820-828.
31. 31. Häfner D, Germann PG, Hauschke D. Effects of Lung Surfactant Factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF. Pulm Pharmacol 1994: 7: 319-332.
32. 32. Corcoran JD, Berggren P, Sun B, Halliday HL, Robertson B, Curstedt T. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. Arch Dis Child Fetal Neonatal Ed 1994: 71: F165-F169.
33. 33. Kattwinkel J. Surfactant. Evolving issues. Clin Perinatol 1998: 25: 17-32.
34. 34. Shinwell ES, Robertson B, Saugstadt OD, Halliday HL, Speer CP. Update on surfactant therapy. Biol Neonate 1995: 67: 2-12.
35. 35. Tashiro K, Nishizuka K, Matsumoto Y, Ohta K, Suzuki Y, Kobayashi T. Modified natural and synthetically reconstituted surfactant therapies for acute lung injury caused by endotoxin in rats. Acta Anaesthesiol Scand 1999: 43: 821-828.
36. 36. Holm BA. Surfactant inactivation in adult respiratory distress syndrome. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary Surfactant. From Molecular Biology to Clinical Practice. Amsterdam: Elsevier, 1992: 665-684.
37. 37. Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994: 20: 6-11.
38. 38. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991: 29: 353-356.
39. 39. Robertson B. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS). Monaldi Arch Chest Dis 1998: 53: 64-69.
40. 40. Berggren P, Linderholm B. Evaluation of surfactant function by assessment of microbubble stability. Biol Neonate 1996: 69: 214 (Abstract).
41. 41. Chida S. A stable microbubble test for antenatal and early neonatal diagnosis of surfactant deficiency. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York: Marcel Dekker, 1995: 107-120.